VIRIOS THERAPEUTICS INC (VIRI) Forecast, Price Target & Analyst Ratings

NASDAQ:VIRI • US92829J1043

Current stock price

0.155 USD
+0.02 (+12.4%)
At close:
0.1452 USD
-0.01 (-6.32%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VIRIOS THERAPEUTICS INC (VIRI).

Forecast Snapshot

Consensus Price Target

Price Target
$1.43
+ 821.29% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Nov 11, 2024
Period
Q4 / 2024
EPS Estimate
-$0.07
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$1.43
Upside
+ 821.29%
From current price of $0.16 to mean target of $1.43, Based on 8 analyst forecasts
Low
$0.20
Median
$1.02
High
$3.15

Price Target Revisions

1 Month
0.00%
3 Months
-22.22%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for VIRI. The average price target is 1.43 USD. This implies a price increase of 821.29% is expected in the next year compared to the current price of 0.155.
The average price target has been revised downward by 22.22% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

VIRI Current Analyst RatingVIRI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

VIRI Historical Analyst RatingsVIRI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
VIRI was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about VIRI.
In the previous month the buy percentage consensus was at a similar level.
VIRI was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2024-10-09HC Wainwright & Co.Maintains Neutral -> Neutral
2024-08-09HC Wainwright & Co.Maintains Neutral -> Neutral
2024-06-20Maxim GroupInitiate Buy
2022-09-20HC Wainwright & Co.Downgrade Buy -> Neutral
2021-12-15HC Wainwright & Co.Initiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Nov 11, 2024
Period
Q4 / 2024
EPS Estimate
-$0.07
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-19.00%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
8.33%

Next Earnings Summary

VIRI is expected to report earnings on 11/11/2024. The consensus EPS estimate for the next earnings is -0.07 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2024 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
VIRI revenue by date.VIRI revenue by date.
N/AN/AN/AN/AN/A
96.91%		N/A
40.00%		N/A
30.60%
EBITDA
YoY % growth
VIRI ebitda by date.VIRI ebitda by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
VIRI ebit by date.VIRI ebit by date.
-1.96M-2.18M
-11.22%		-10.01M
-359.17%		-15.64M
-56.24%		-12.32M
21.23%		-5.447M
55.79%		N/A
-1.04%		N/A
-22.94%		N/A
-60.61%		N/A
77.92%		N/A
284.12%		N/A
28.64%		N/A
45.14%
Operating Margin
VIRI operating margin by date.VIRI operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
VIRI eps by date.VIRI eps by date.
N/AN/AN/AN/A-1.31
37.35%		-0.28
78.63%		N/A
19.86%		N/A
25.00%		N/A
-30.30%		N/A
-234.88%		N/A
93.06%		N/A
260.00%		N/A
262.50%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.07
-19.00%		-0.05
27.14%		-0.05
-2.00%		-0.05
97.51%		-0.06
14.29%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-1.558M
-36.85%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

VIRI Yearly Revenue VS EstimatesVIRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 20M 40M 60M
VIRI Yearly EPS VS EstimatesVIRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.5 -1 -1.5 -2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
6.76%
EPS Next 5 Year
12.70%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

VIRIOS THERAPEUTICS INC / VIRI Forecast FAQ

Can you provide the average price target for VIRIOS THERAPEUTICS INC stock?

8 analysts have analysed VIRI and the average price target is 1.43 USD. This implies a price increase of 821.29% is expected in the next year compared to the current price of 0.155.

When does VIRIOS THERAPEUTICS INC (VIRI) report earnings?

VIRIOS THERAPEUTICS INC (VIRI) will report earnings on 2024-11-11, before the market open.

What are the consensus estimates for VIRI stock next earnings?

The consensus EPS estimate for the next earnings of VIRIOS THERAPEUTICS INC (VIRI) is -0.07 USD and the consensus revenue estimate is 0 USD.